Relapsed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia responds well to a combination of modified hyper‐CVAD, blinatumomab and tyrosine kinase inhibitor... by Gaétan Basile, Jean Galtier, Titouan Cazaubiel, Edouard Forcade, Emilie Klein, Audrey Bidet, Carmen Botella‐Garcia, Clémence Mediavilla, Laurence Clement, Pierre‐Yves Dumas, Arnaud Pigneux, Thibaut Leguay

Get full text

FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the... by Pierre Peterlin, Joëlle Gaschet, Pascal Turlure, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Ana Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Jose-Miguel Torregrosa-Diaz, Louis Drevon, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sophie Dimicoli-Salazar, Maxime Jullien, Pierre Fenaux, Patrice Chevallier.

Get full text

Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study by Jules Higué, Corentin Orvain, Pierre-Yves Dumas, Pierre Peterlin, Marie-Anne Hospital, Sabrina Barrière, Audrey Couturier, Martin Carre, Areti Chantzi, Emmanuelle Tavernier, Éric Delabesse, Audrey Bidet, Anne Bouvier, Marie-Joelle Mozziconacci, Lauren Véronèse, Cédric Pastoret, Sylvie Tondeur, Pascale Flandrin-Gresta, Sébastien Lachot, Marine Cazaux, Sylvain Thépot, Edouard Forcade, Patrice Chevallier, Raynier Devillier, Gaspar Aspas Requena, Sarah Bertoli, Arnaud Pigneux, Christian Récher

Get full text